GlaxoSmithKline PLC Director/PDMR Shareholding (9103W)

TIDMGSK

RNS Number : 9103W

GlaxoSmithKline PLC

29 April 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4R(1)(a) and (c) I give details of changes in the interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR') who acquired Ordinary Shares ('Shares') in GlaxoSmithKline plc ('GSK') at a price of 1496.49 pence per Share, following the re-investment of the dividend paid to shareholders on 14 April 2016.

 
 
   Director/PDMR         Shares 
-------------------  ---------- 
 Sir Andrew Witty     2,257.407 
-------------------  ---------- 
 Mr R Connor            552.391 
-------------------  ---------- 
 Mr S A Hussain       1,460.067 
-------------------  ---------- 
 Mr D S Redfern       2,129.312 
-------------------  ---------- 
 Dr M M Slaoui            4.719 
-------------------  ---------- 
 Ms C Thomas          2,692.384 
-------------------  ---------- 
 Mr P C Thomson       1,002.153 
-------------------  ---------- 
 Dr P J T Vallance    3,827.535 
-------------------  ---------- 
 Ms E Walmsley        2,705.444 
-------------------  ---------- 
 
 
 
    Connected Person      Shares 
---------------------  --------- 
 Mrs K Thomson 
  (Connected Person 
  to Mr P C Thomson)     251.103 
---------------------  --------- 
 

GSK was informed of these allocations on 28 April 2016.

V A Whyte

Company Secretary

29 April 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHQKLFLQZFFBBL

(END) Dow Jones Newswires

April 29, 2016 12:14 ET (16:14 GMT)